3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Withdrawn
1
Terminated
1
Recruiting
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Pancreatic Neoplasms
29
Breast Neoplasms
21
Carcinoma, Non-Small-Cell Lung
20
Triple Negative Breast Neoplasms
15
Lung Neoplasms
10
Colorectal Neoplasms
8
Neoplasm Metastasis
7
Esophageal Squamous Cell Carcinoma
7
Stomach Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Esophageal Neoplasms
5
Ovarian Neoplasms
4
Biliary Tract Neoplasms
4
Head and Neck Neoplasms
3
Gallbladder Neoplasms
3
Fallopian Tube Neoplasms
3
Carcinoma, Pancreatic Ductal
3
Vaccinia
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasms by Site
2
Neoplasms
2
Locally Advanced Pancreatic Cancer
2
Gastrointestinal Neoplasms
2
Endometrial Neoplasms
2
Brain Neoplasms
2
Advanced Solid Tumors
2
Adenocarcinoma
2
Ureteral Neoplasms
1
Thyroid Neoplasms
1
Squamous Non-small Cell Lung Cancer
1
Interventions
Magnetic Resonance Spectroscopy
51
Specimen Handling
42
enzalutamide
36
Androgen Antagonists
35
Radiosurgery
33
Radiotherapy
31
darolutamide
26
Prednisone
26
Abiraterone Acetate
25
Leuprolide
22
Docetaxel
22
apalutamide
21
abiraterone
19
Pluvicto
19
Standard of Care
18
Triptorelin Pamoate
17
Radiation
17
Biopsy
16
relugolix
15
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
15
Goserelin
14
Blood Specimen Collection
13
gallium 68 PSMA-11
12
X-Rays
11
Surveys and Questionnaires
11
pembrolizumab
10
luprolide acetate gel depot
10
Carboplatin
10
Methods
9
Interviews as Topic
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Prostatic Neoplasms
×
130-nm albumin-bound paclitaxel
×
Clear all
NCT06769425
2025-06-24
HS-10502
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1
Recruiting
157 enrolled